<DOC>
	<DOCNO>NCT01319968</DOCNO>
	<brief_summary>Postpartum dyspareunia ( PD ) recognize phenomenon : estimate 50-60 % woman dyspareunia 6 7 week follow delivery , 33 % 17 % still report pain intercourse three six month delivery , respectively . Studies evaluate prevalence cause PD refer primarily obstetric trauma , vaginal tear , episiotomy , mode repair damage pelvic floor muscle probable cause PD . These study refer estrogen deficiency possible effect breastfeed vaginal atrophy contribution PD . Comparison vaginal delivery cesarean section reveal difference prevalence PD two group , accord finding assume mechanical trauma vagina pelvic floor delivery main cause development PD . Vaginal atrophy due estrogen deficiency common cause postmenopausal dyspareunia . With estrogen deficiency , profound change occur vagina : vaginal mucosa become thin pale hyperemic loose flexibility . Blood flow decrease , normal vaginal discharge reduce , maturation epithelial cell take place absence estrogen . Women estrogen deficiency may complain dryness , pruritus , irritation , burning , dysuria , pain dyspareunia . These change reversible estrogen , give systemically topically , cause resolution clinical finding , well disappearance symptom several week . Similar postmenopausal patient , breastfeed woman immediately delivery , experience decline estrogen level , decline may persist long lactation continue . Therefore , many woman delivery may experience vaginal atrophy due transitional lack estrogen . It possible atrophy cause high rate PD . Our clinical experience show many woman present postpartum dyspareunia vaginal atrophy , vaginal atrophy responsible part complaint . Although gynecologist recognize atrophy easily menopausal woman , vaginal atrophy recognize correctly puerperal patient therefore receive attention proper treatment . The aim study characterize phenomenon postpartum vaginal atrophy term prevalence , risk factor duration , association vaginal atrophy postpartum dyspareunia . We also intend evaluate effect vaginal treatment estriol cream 0.1 % ( Ovestin cream ) postpartum dyspareunia . The study expand knowledge regard postpartum dyspareunia enable formulating recommendation evaluation treatment PD .</brief_summary>
	<brief_title>Postpartum Dyspareunia Resulting From Vaginal Atrophy</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Dyspareunia</mesh_term>
	<criteria>Healthy , puerperal woman willing participate , 18 year old . Patients puerperal complication : bleeding , fever , endometritis . Patients significant systemic disease . Patients conceive study . Patients willing participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Postpartum dyspareunia</keyword>
	<keyword>Vaginal atrophy</keyword>
</DOC>